Extending human healthspan.
NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome. We leverage technologies like single cell genomics, machine learning, and high-throughput functional assays to reveal epigenetic features of aging and discover rejuvenating interventions. Our first programs target the aging liver, immune, and vascular systems as stepping stones to significantly extending human healthspan.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Oct 2025
May 2025
May 2023
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
